Net loss of Parmax Pharma reported to Rs 0.76 crore in the quarter ended June 2025 as against net profit of Rs 0.01 crore during the previous quarter ended June 2024. Sales declined 75.19% to Rs 1.94 crore in the quarter ended June 2025 as against Rs 7.82 crore during the previous quarter ended June 2024.
| Particulars | Quarter Ended | ||
| Jun. 2025 | Jun. 2024 | % Var. | |
| Sales | 1.94 | 7.82 | -75 |
| OPM % | -12.89 | 6.52 | - |
| PBDT | -0.52 | 0.41 | PL |
| PBT | -0.76 | 0.01 | PL |
| NP | -0.76 | 0.01 | PL |
Powered by Capital Market - Live News